About this trial
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion).
Ambulate independently and without the use of assistive devices or orthoses.
Willing and interested in participating.
Disqualifiers
Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
History of premature birth.
Trial population
Subjects will be recruited from the regional community, including convenience sample of children. Subjects will be recruited by word of mouth, posted flyers, and advertised through the RML website and MB social media.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Observation
Other interventionThis project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.
Treatment groups
Trial outcomes
Primary outcomes
Observation-based movement analyses
The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.